A detailed history of Guardian Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Guardian Wealth Management, Inc. holds 27,510 shares of ABBV stock, worth $4.69 Million. This represents 3.87% of its overall portfolio holdings.

Number of Shares
27,510
Previous 27,175 1.23%
Holding current value
$4.69 Million
Previous $4.95 Million 4.65%
% of portfolio
3.87%
Previous 4.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $51,854 - $60,554
335 Added 1.23%
27,510 $4.72 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $61,370 - $69,926
384 Added 1.43%
27,175 $4.95 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $63,571 - $71,596
-462 Reduced 1.7%
26,791 $4.15 Million
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $23,511 - $27,218
176 Added 0.65%
27,253 $4.06 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $80,168 - $99,764
605 Added 2.29%
27,077 $3.65 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $66,520 - $76,608
460 Added 1.77%
26,472 $4.22 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $65,420 - $78,456
473 Added 1.85%
26,012 $4.21 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $67,373 - $77,272
502 Added 2.01%
25,539 $3.43 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $184,961 - $235,146
1,344 Added 5.67%
25,037 $3.84 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $48,832 - $60,587
370 Added 1.59%
23,693 $3.84 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $2.51 Million - $3.17 Million
23,323 New
23,323 $3.16 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Guardian Wealth Management, Inc. Portfolio

Follow Guardian Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Management, Inc. with notifications on news.